You are here

AstraZeneca

AstraZeneca inhaler lags GSK drug in lung disease trial

Reuters

Thu, 08/23/18 - 11:54 am

clinical trials

Bevespi Aerosphere

AstraZeneca gets further approval for Tagrisso in Japan

Pharmaforum

Tue, 08/21/18 - 10:08 am

non-small cell lung cancer

AstraZeneca, its new HQ delayed and way over budget, weighs a construction partner swap: report

Fierce Pharma

Mon, 08/20/18 - 10:41 pm

AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3

Fierce Biotech

Mon, 08/20/18 - 10:09 am

clinical trials

PARP inhibitors show promise for treating ALS and other brain disorders

Fierce Biotech

Thu, 08/9/18 - 10:04 pm

PARP inhibitors

Drug firms fight US government’s Iraq corruption probe

Pharmaforum

Thu, 08/9/18 - 08:46 pm

AstraZeneca to Pay $110 Million to Settle Texas Drug Suits

Yahoo/Bloomberg

Tue, 08/7/18 - 11:51 pm

Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster

Endpoints

Mon, 08/6/18 - 09:53 am

Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1

CP Wire

Fri, 08/3/18 - 09:25 am

Array Biopharma

neurofibromatosis

Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1

Fri, 08/3/18 - 09:23 am

Array Biopharma

Justice Department probes claims that AstraZeneca bribed Iraqi terrorists to win contracts

Fierce Pharma

Tue, 07/31/18 - 11:15 am

AstraZeneca joins U.S. drug price freeze for rest of 2018

Reuters

Fri, 07/27/18 - 11:55 am

AstraZeneca’s selumetinib flops in thyroid cancer, adding to list of failures

Fierce Biotech

Fri, 07/27/18 - 10:00 am

pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in

RAPS.org

Thu, 07/26/18 - 07:28 pm

Gilead Sciences

drug-drug interactions

proton pump inhibitors

Sparks of growth for AstraZeneca hide cancer trial fail

Biopharma Divd

Thu, 07/26/18 - 11:45 am

AstraZeneca offloads Atacand in Europe for $200M

Biopharma Dive

Wed, 07/25/18 - 03:13 pm

Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease

Fierce Biotech

Tue, 07/24/18 - 10:32 am

Parkinson's Disease

NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used

Fierce Pharma

Sun, 07/22/18 - 12:21 pm

AstraZeneca to stockpile drugs as Brexit 'safety net'

Reuters

Wed, 07/18/18 - 11:02 pm

Hitting cancer early: AstraZeneca's bid to outmaneuver rivals

Yahoo/Reuters

Fri, 07/6/18 - 10:11 am

Pages